Steward Partners Investment Advisory’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.5K Hold
16,340
﹤0.01% 2705
2025
Q4
$57.4K Buy
16,340
+2,500
+18% +$8.56K ﹤0.01% 2600
2025
Q3
$45.1K Hold
13,840
﹤0.01% 2656
2025
Q2
$33.9K Buy
13,840
+2,500
+22% +$12.7K ﹤0.01% 2670
2025
Q1
$75.6K Buy
11,340
+4,640
+69% +$45.8K ﹤0.01% 2180
2024
Q4
$84.2K Sell
6,700
-1,800
-21% -$27.1K ﹤0.01% 2066
2024
Q3
$157K Buy
8,500
+1,000
+13% +$20.5K ﹤0.01% 1648
2024
Q2
$161K Hold
7,500
﹤0.01% 1547
2024
Q1
$202K Buy
7,500
+2,500
+50% +$71K ﹤0.01% 1429
2023
Q4
$150K Hold
5,000
﹤0.01% 1498
2023
Q3
$102K Buy
5,000
+500
+11% +$9.09K ﹤0.01% 1555
2023
Q2
$89.4K Hold
4,500
﹤0.01% 1631
2023
Q1
$77.1K Buy
4,500
+2,500
+125% +$49K ﹤0.01% 1688
2022
Q4
$39.1K Buy
+2,000
New +$36.8K ﹤0.01% 1940

Other funds holding RCKT